MedTrace Logo

Epigenetics Modifications in Morbid Obesity and Obstructive Sleep Apnea Patients: The EPIMOOSA Study

NCT03995836 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2019-06-24

No results posted yet for this study

Summary

This study evaluates epigenetics in morbid obese patients who are waiting for bariatric surgery. A home cardiopulmonary polygraphy is performed to evaluate for the presence of sleep-disordered breathing. The principal investigator make the decision of starting CPAP among patients with obstructive sleep apnea according to current clinical guidelines. One year follow up after bariatric surgery will be performed. A total of 5 visits will be scheduled: two of them before bariatric surgery and 3 after (3, 6 and 12 months).

At every visit, all patients had: sleep questionaries, blood samples, EKG-Holter and spirometry are collected.

Conditions

Interventions

DEVICE

CPAP

Decision of CPAP treatment is according to clinical guidelines

PROCEDURE

Bariatric Surgery

All patients.

Sponsors & Collaborators

  • Aragon Institute of Health Sciences

    lead OTHER

Principal Investigators

  • JAVIER LAZARO SIERRA, MD · Hospital Royo Villanova

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-01
Primary Completion
2016-07-01
Completion
2018-07-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03995836 on ClinicalTrials.gov